↓ Skip to main content

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate…

Overview of attention for article published in Arthritis Research & Therapy, November 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
Published in
Arthritis Research & Therapy, November 2009
DOI 10.1186/ar2859
Pubmed ID
Authors

Vibeke Strand, Philip Mease, Gerd R Burmester, Enkeleida Nikaï, Geoffroy Coteur, Ronald van Vollenhoven, Bernard Combe, Edward C Keystone, Arthur Kavanaugh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Norway 1 <1%
Finland 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 116 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 17%
Student > Master 17 14%
Other 14 11%
Student > Bachelor 14 11%
Student > Ph. D. Student 12 10%
Other 19 16%
Unknown 25 20%
Readers by discipline Count As %
Medicine and Dentistry 48 39%
Nursing and Health Professions 10 8%
Agricultural and Biological Sciences 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 11 9%
Unknown 34 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2020.
All research outputs
#5,447,195
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#1,264
of 3,381 outputs
Outputs of similar age
#21,295
of 106,667 outputs
Outputs of similar age from Arthritis Research & Therapy
#8
of 35 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.